Emerging Catheter-Based Devices: A New Era for Heart Failure Management

Abstract

Heart failure (HF) remains a major cause of morbidity and mortality worldwide despite advancements in its management. Although existing therapies such as beta-blockers, angiotensin receptor-neprilysin inhibitors, and implantable cardiac defibrillators (ICD) have improved clinical outcomes, the need for more advanced treatment modalities is pressing [1]. Recently, catheter-based devices have emerged as promising interventions, targeting key pathophysiological mechanisms in HF progression [2]. The editorial highlights the potential of these novel devices in managing HF patients and the challenges ahead.